Skip to main content
Premium Trial:

Request an Annual Quote

Spain's BlackBio Raises $3M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Spanish personalized medicine company BlackBio has raised €3 million ($4.1 million) through private and public funding, it announced on Thursday.

The funds will be used to continue development of diagnostic tools and international expansion, it said. Investors in the round include Inibsa Laboratories and NanoBiz.

The company, based in Madrid, Spain, develops products based on genetics, genomics, and proteomics and among products it has available is its BlackZyme DNA Polymerase for DNA amplification and a diagnostic test for fungal infections.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.